Paul A. Stone bought IDYA once, on May 28, 2019

Paul A. Stone is a biotechnology executive and corporate insider who has served in senior legal, operating, and finance roles at IDEAYA Biosciences. He joined IDEAYA in 2018 as Senior Vice President, General Counsel, and Head of Operations, and was later promoted to Chief Financial Officer in 2019; IDEAYA describes him as bringing more than 20 years of legal, financial, and management experience to the company.(

Stone’s career includes leadership positions at 5AM Ventures (Partner, General Counsel, and Chief Operating Officer), Ethos Pharmaceuticals (General Counsel), Ilypsa, and Symyx Technologies, along with earlier legal work as an associate at Senniger Powers. His LinkedIn profile lists a J.D. from the University of Wisconsin Law School and shows that he later moved from IDEAYA to Matterworks as Chief Financial Officer and Head of Corporate Development in 2026.( IDEAYA is an oncology-focused biotechnology company developing synthetic lethality medicines and immuno-oncology therapies.(

Written by Perplexity from public sources.